Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 June 2021 | Story Dr Cindé Greyling | Photo Supplied

A brand-new modular space for students was recently completed on the University of the Free State Bloemfontein Campus. The Modular Lecturing Space and Assessment Centre is a bold step to engage with the changing academic environment. It is an example of how collaboration between UFS faculties, the Centre for Teaching and Learning, ICT Services, and University Estates can create cutting-edge and innovative learning and teaching environments.

One space, many functions

The centre, which took 22 months to complete, consists of innovative multi-functional spaces that can be used for large- and small-scale lectures or group work. The biggest venue, which can accommodate up to 980 students, can also be converted into five acoustically separate venues with a variety of table configurations depending on the educational needs. 

In line with the newly adopted blended learning approach, the digital infrastructure in the centre allows for the seamless integration of technology, as all the spaces are equipped with state-of-the-art audio-visual equipment. The computer laboratory and assessment centre, which can accommodate 800 students, can be used for examination or teaching and can be divided into two separate areas if needed. 

Functional study stops 

The centre offers an area where students can pause and study in groups around tables with a laptop-friendly study ledge that runs along the length of the space. Sufficient power points allow students to recharge their devices in an aesthetically pleasing space that promotes optimal engagement with learning. 

The design brief for this multifunctional space was a collaborative effort between professionals and UFS departments to ensure the most efficient use of space and purpose. The overall focus was on effectiveness and efficiency, which is part of University Estates’ strategy to maximise the use of space.

More to this than meets the eye

The building integrates into its environment with waterwise gardens and numerous indigenous trees planted around the permanent outdoor seating, which can also be used as informal learning spaces. The landscaping is seamlessly accessible with ramps and tactile paving. 

Modern, fully inclusive ablution facilities can accommodate high volumes of traffic, and rainwater is collected in 44 tanks with a capacity of 79 000 litres for watering the landscape, as well as emergency water supply to flush water closets. Heat pump air-conditioning systems with individual control for each room are connected to the campus building management system for effective energy control. 

Further expansion

Phase 2 of the project will entail a 24/7 study space that will accommodate 250 students. The venue will also provide a small recreation area. Completion is scheduled for December 2021.

Although the project team was faced with COVID-19 restrictions during construction, they managed to complete the building within the agreed budget and quality measures. The team is looking forward to creating more functional spaces on the UFS campuses. 

Take a tour of the new Modular Lecturing Space and Assessment Centre Building:

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept